SWK Holdings is a specialized finance company listed on Nasdaq (SWKH) with a focus on the global healthcare sector. Founded in 1996, the company offers bespoke capital solutions for commercial-stage life science companies and royalty owners. With the slogan "Bespoke capital solutions for commercial-stage life science companies and royalty owners," SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value.
SWK believes its financing structures achieve an optimal partnership for companies, institutions, and inventors seeking capital for expansion, capital, and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. This approach sets SWK apart in the life science finance market. The company's headquarters is in the United States.
Notably, the latest investment made by SWK Holdings was a $3.00M post-IPO debt investment on 30 October 2023. This investment signifies the company's ongoing commitment to providing financial support to partners in the healthcare sector.
For more information about the company and its role in the life science finance market, interested parties can visit the company's website at www.swkhold.com.
No recent news or press coverage available for SWK Holdings Corporation.